Thoracoabdominal Asynchrony and Respiratory Distress

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28-17
SponsorMassachusetts General Hospital

About this trial

The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions.

AIMS To determine if the TAA-monitoring device can be used to detect differences in respiratory synchrony in a manner that is clinically applicable. The investigators hope that the device will detect 1) major asynchrony events in a timely manner so as to prompt clinician intervention during future use; and 2) asynchrony events that may be less visible to the naked eye that may be precursors to more severe events.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients 28-days to 17-years of age

who have respiratory distress and those who do not have respiratory distress

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Objectively monitoring thoracoabdominal asynchrony

    Diagnostic test

    Objectively monitoring thoracoabdominal asynchrony

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Respiratory insufficiency or distressActive comparator 1 intervention
Group B: No respiratory insufficiency or distress.Sham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Objectively determine thoracoabdominal asynchrony

The investigators aim to objectively measure the frequency of asynchrony over time (minutes).

Time frame
Over 30 - 7200 minutes

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.